The Claim
Intensive blood pressure control targeting diastolic pressure alone is associated with a 48% reduction in all-cause mortality in adults with type 2 diabetes, whereas targeting systolic pressure alone or both systolic and diastolic pressure shows no significant mortality benefit.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with type 2 diabetes, focusing blood pressure treatment only on lowering diastolic pressure is linked to a 48% lower risk of death from any cause, while focusing on systolic pressure alone or both pressures together does not show a significant reduction in death risk.
See the scientific wording
Intensive blood pressure control targeting diastolic pressure alone is associated with a 48% reduction in all-cause mortality in adults with type 2 diabetes, based on subgroup analysis of two trials, whereas targeting systolic pressure alone or both components shows no significant mortality benefit.
Lowering the bottom number of blood pressure improves blood flow to the heart muscle during its resting phase, which prevents heart tissue from being starved of oxygen, especially in people with diabetes who have narrowed heart arteries. This stops heart damage and death.
What the research says
1 studyIn people with type 2 diabetes, focusing only on lowering the bottom number of blood pressure (diastolic) was linked to nearly half fewer deaths, but lowering just the top number or both didn’t show the same benefit. The study found this exact pattern.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.